Eyegate Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Leadership Update, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits